Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis

OBJECTIVES: Osteoporosis is a rapidly rising cause of concern for elderly patients. Various classes of drugs are available in the market. Bisphosphonates are considered as a first-line therapy for the prevention and treatment. Denosumab is an antiresorptive agent which is a RANK ligand inhibitor. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Benjamin, Biju, Benjamin, Mridula Ambwani, Swe, Myint, Sugathan, Sandheep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372735/
https://www.ncbi.nlm.nih.gov/pubmed/30775470
http://dx.doi.org/10.1016/j.afos.2016.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372735/
https://www.ncbi.nlm.nih.gov/pubmed/30775470
http://dx.doi.org/10.1016/j.afos.2016.03.003

Ejemplares similares